Evaluation of a continuous glucose sensor in patients with diabetes on hemodialysis
Dr. Amit Bagga
Windsor Regional Hospital
FUNDER: Tayfour-Emara Excellence in Research & Education Fund
DURATION: 2023-2024
The prevalence of end-stage renal disease (ESRD) is increasing rapidly. Continuous glucose monitors (CGMs) have become widely available and effective at monitoring glucose levels in patients with ESRD. The Flash Glucose Monitor (FGM) is a type of CGM that was introduced in 2014 and allows patients to obtain glucose values instantly by scanning the glucose sensor with a reader, providing live-on-demand glucose data. This project analyzes the ability of an FGM, specifically the Freestyle Libre 2, to accurately measure blood glucose levels in hemodialysis patients with diabetes.
Benefits of FGMs will be extended to the hemodialysis population in Canada, specifically patients at Windsor Regional Hospital in Windsor, Ontario, by shedding light on its accuracy and ability to guide glycemic control.
